September 2021 | VOL. 18, ED. 2
Colour PDF Greyscale PDF In this issue Real people, real stories: the lived experience we would love to be without Time to Remember. Time to Act: International Overdose Awareness Day 2021 ‘These are our patients, our friends, our family members’: Q&A with Dr Kimberly Sue
August 2021 | VOL. 18, ED. 1
Colour PDF Greyscale PDF In this issue Take-home Naloxone: The revival roadshow dodging potholes aplenty Crunching numbers to care for clients: User data is key for NSPs, if they can get it Second Life: Heart-starting stories from the naloxone front lines ‘We’re a pioneer organisation’: Q&A with Scott Wilson
July 2021 | VOL. 17, ED. 5
Colour PDF Greyscale PDF In this issue Shine and rise: have vein finders finally hit the spot? Needle points and syringes: what you need to know Doing what needs to be ‘done: record number of Australians in pharmacotherapy Hopeful Irish eye Australia’s safe-injecting success
May/June 2021 | VOL. 17, ED. 4
Colour PDF Greyscale PDF In this issue Viral Load: Covid angst, tainted drugs and heroin droughts could create a dangerous new normal Hard Knocks: Some know violence and anger intimately through the scene. Others always have. Scotch, ice and coke: Booze and amphetamines driving our national addiction, but cocaine is coming It just requires unconventional […]
April 2021 | VOL. 17, ED. 3
Colour PDF Greyscale PDF In this issue Hep Hep Hooray! The miracle drug beating hepatitis C Looking good? For the buff, the beautiful and the body-hackers, perfection comes at a price Jude Byrne: tireless advocate for people who use drugs Dutch Courage: How a studious outsider became the saviour of Sydney’s mean streets.
March 2021 | VOL. 17, ED. 2
Colour PDF Greyscale PDF In this issue Pandemic watch: close services? Suffering in silence: people who use drugs overlooked in mental health The Engagement Game: do frontline workers support mental health? ‘Don’t follow our lead’: From Russia with Ivan Varentsov
February 2021 | VOL. 17, ED. 1
Colour PDF Greyscale PDF In this issue Getting under your skin: revolution in opioid treatment A dangerous fantasy: spiking GHB-related harms Bloody survey: tracking HIV and HCV for 25 years Foundations of instability: homelessness and addiction Police and drug crime: a new way to tame the beast
June 2019 | VOL. 16, ED. 4
Colour PDF Greyscale PDF In this issue When a broken heart could kill – the dangers of endocarditis A Scottish world-first and the lessons that could save lives here Paint the town purple to mark International Overdose Awareness Day
May 2019 | VOL. 16, ED. 3
Colour PDF Greyscale PDF In this issue The two of us: Mitch and Tammy Naloxone: right dose, right place, right time The rise and rise of pregabalin prescriptions and ambulance callouts Naloxone – the essential guide
April 2019 | VOL. 16, ED. 2
Colour PDF Greyscale PDF In this issue ‘Done’, ‘bupe’ and ‘subby’ – what?!? The today and tomorrow of pharmacotherapy Pharmacotherapy key to effective hepatitis C treatment Shush! Confidentiality and anonymity in the NSP/CNP Drugs and teeth: ‘It’s a big issue’